NEOGENOMICS, INC. (NEO) Free cash flow 2016–2025
NEOGENOMICS, INC. (NEO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$21.8MFY2025 · since FY2016: $13.9M → -$21.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$21.8M | +36.0% |
| FY2024 | -$34.0M | -10.9% |
| FY2023 | -$30.7M | +68.3% |
| FY2022 | -$96.9M | -6.6% |
| FY2021 | -$90.9M | -228.8% |
| FY2020 | -$27.6M | -927.4% |
| FY2019 | $3.3M | -89.0% |
| FY2018 | $30.5M | +601.1% |
| FY2017 | $4.3M | -68.8% |
| FY2016 | $13.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice